INDIAN pharmaceutical firm Aurobindo Pharma Ltd. plans to establish a facility in the Philippines to manufacture generic pharmaceuticals and active pharmaceutical ingredients (APIs), the Philippine Economic Zone Authority (PEZA) said last week.
PEZA Director General Tereso Panga met with Aurobindo Pharma's Chief Business Officer Ravikiran Namburi, Senior Vice President Debashis Sarkar, and General Manager Aravind Babu at the PEZA head office last September 26, following a July 2024 meeting in India.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.